ZAROXOLYN Side Effects

6783536-8 | Asthenia, Blood Creatinine Increased, Blood Urea Increased, Dehydration, Hypokalaemia, Nausea, Weight Decreased
on Jun 07, 2010 Male patient from UNITED STATES , 64 years of age, weighting 218.9 lb, was diagnosed with osteoarthritis (What is osteoarthritis?), rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood creatinine increased, blood urea increased, dehydration, hypokalaemia, nausea (What is nausea?), weight decreased. Zaroxolyn dosage: (oral). During the same period patient was treated with LASIX ((oral)) (View Lasix Review and Lasix Label ), NEXIUM (View Nexium Review and Nexium Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6783536-8 | Asthenia, Blood Creatinine Increased, Blood Urea Increased, Dehydration, Hypokalaemia, Nausea, Weight Decreased
Patient was taking Zaroxolyn (View Usage). Patient had the following side effects: asthenia, blood creatinine increased, blood urea increased, dehydration, hypokalaemia, nausea (What is nausea?), weight decreased on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 218.9 lb, was diagnosed with osteoarthritis (What is osteoarthritis?), rheumatoid arthritis (What is rheumatoid arthritis?) and. Zaroxolyn dosage: (oral). During the same period patient was treated with CELECOXIB (View Celecoxib Review and Celecoxib Label ), LASIX ((oral)) (View Lasix Review and Lasix Label ), NEXIUM (View Nexium Review and Nexium Label ), RANITIDINE HYDROCHLORIDE (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ). Patient was hospitalized.

6162956-9 | Dyspnoea, Oedema Peripheral, Renal Failure Acute, Weight Increased
Adverse event was reported on Apr 02, 2009 by a Female patient taking Zaroxolyn (View Usage) (Dosage: ) was diagnosed with polyuria, pulmonary arterial hypertension and. Location: UNITED STATES , 62 years of age, After Zaroxolyn was administered, patient had the following side effects: dyspnoea, oedema peripheral, renal failure acute, weight increased. During the same period patient was treated with LETAIRIS (5 Mg, Po) (View Letairis Review and Letairis Label ), LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

6087928-4 | Pruritus, Urticaria
on Feb 18, 2009 Female patient from UNITED STATES , 65 years of age, weighting 176.0 lb, was treated with Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, urticaria. Zaroxolyn dosage: 1 Tab Qd Po.


6081743-3 | Blood Sodium Decreased, Fatigue, Joint Swelling
on Jun 19, 2008 Female patient from UNITED STATES , 62 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Zaroxolyn (View Usage). Patient had the following side effects: blood sodium decreased, fatigue, joint swelling. Zaroxolyn dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), REVLIMID (25 Mg /d) (View Revlimid Review and Revlimid Label ). Patient was hospitalized.

6020632-7 | Arrhythmia, Asthenia, Blood Pressure Decreased, Body Temperature Decreased, Headache, Muscle Spasms, Nausea, Shock
Patient was taking Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), asthenia, blood pressure decreased, body temperature decreased, headache (What is headache?), muscle spasms, nausea (What is nausea?), shock on Dec 24, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 242.5 lb, was diagnosed with ascites, cardiac failure congestive, oedema, nutritional support (What is nutritional support?) and. Zaroxolyn dosage: 2 1/2 Mg Once A Day By Mouth. During the same period patient was treated with INFANT FORMULA (PB NUTRITIONAL LLC (1/2 Measure Once A Day By Mouth) (View Infant Formula (pb Nutritional Llc Review and Infant Formula (pb Nutritional Llc Label ).

5939673-0 | Dehydration, Syncope
Adverse event was reported on Oct 30, 2008 by a Male patient taking Zaroxolyn (View Usage) (Dosage: 5 Mg Every Day Po) was diagnosed with oedema and. Location: UNITED STATES , 88 years of age, weighting 374.8 lb, Patient experienced the following unwanted or unexpected effects: dehydration, syncope. During the same period patient was treated with LASIX (40 Mg Daily Po) (View Lasix Review and Lasix Label ). Patient was hospitalized.

5850420-3 | Asthenia, Feeling Abnormal, Hypokalaemia
on Jul 31, 2008 Male patient from UNITED STATES , 87 years of age, weighting 125.2 lb, was treated with Zaroxolyn (View Usage). Patient had the following side effects: asthenia, feeling abnormal, hypokalaemia. Zaroxolyn dosage: .

5220482-5 | Chest Pain, Hypokalaemia
on Jan 25, 2007 Female patient from UNITED STATES , weighting 240.0 lb, was diagnosed with hypertension and was treated with Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: chest pain (What is chest pain?), hypokalaemia. Zaroxolyn dosage: 2.5 Mg Po Qd. During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5056288-X | Asthenia, Blood Chloride Decreased, Blood Creatinine Increased, Blood Sodium Decreased, Dehydration, Fatigue
Patient was taking Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, blood chloride decreased, blood creatinine increased, blood sodium decreased, dehydration, fatigue on Jun 29, 2006 from CANADA Additional patient health information: Male patient , 67 years of age, weighting 168.9 lb, was diagnosed with cardiac failure and. Zaroxolyn dosage: 2.5 Mg Prn Po. During the same period patient was treated with NESIRITIDE (1/w) (View Nesiritide Review and Nesiritide Label ), PLAVIX (View Plavix Review and Plavix Label ), COUMADIN (View Coumadin Review and Coumadin Label ), MONOPRIL (View Monopril Review and Monopril Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), NITRO DUR (View Nitro-dur Review and Nitro-dur Label ), CORDARONE (View Cordarone Review and Cordarone Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ). Patient was hospitalized.

5051659-X | Anorexia, Bronchitis, Fluid Retention, Pneumonia, Weight Increased
Adverse event was reported on Jun 28, 2006 by a Female patient taking Zaroxolyn (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease and. Location: UNITED STATES , 60 years of age, weighting 140.3 lb, Patient had the following side effects: anorexia, bronchitis (What is bronchitis?), fluid retention, pneumonia (What is pneumonia?), weight increased. During the same period patient was treated with XOPENEX (View Xopenex Review and Xopenex Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), FLOVENT (View Flovent Review and Flovent Label ), ACTONEL (View Actonel Review and Actonel Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

4989732-4 | Cardiac Failure Congestive, Condition Aggravated, Renal Failure Acute, Troponin Increased
on Apr 14, 2006 Male patient from UNITED STATES , 84 years of age, weighting 136.9 lb, was diagnosed with cardiac failure and was treated with Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: cardiac failure congestive, condition aggravated, renal failure acute, troponin increased. Zaroxolyn dosage: Ni Po. Patient was hospitalized.

4976605-6 | Anxiety, Cardiac Failure, Cerebrovascular Accident, Tendonitis
on Nov 14, 2005 Female patient from UNITED STATES , 57 years of age, weighting 209.4 lb, was diagnosed with hypertension, thyroid disorder, arthralgia, pain in extremity, gout (What is gout?), depression (What is depression?), bacterial infection (What is bacterial infection?) and was treated with Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), cardiac failure, cerebrovascular accident, tendonitis. Zaroxolyn dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VIOXX (View Vioxx Review and Vioxx Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PAXIL (View Paxil Review and Paxil Label ), TEQUIN (View Tequin Review and Tequin Label ). Patient was hospitalized and became disabled.

4974761-7 | Anxiety, Asthenia, Cerebrovascular Accident, Depression, Gouty Arthritis, Hypertension, Memory Impairment, Muscle Spasms, Obesity
Patient was taking Zaroxolyn (View Usage). Patient had the following side effects: anxiety (What is anxiety?), asthenia, cerebrovascular accident, depression (What is depression?), gouty arthritis, hypertension, memory impairment, muscle spasms, obesity (What is obesity?) on Nov 14, 2005 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 211.6 lb, was diagnosed with arthralgia, pain in extremity and. Zaroxolyn dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), VIOXX (View Vioxx Review and Vioxx Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized and became disabled.

4970954-3 | Hypokalaemia, Syncope
Adverse event was reported on Apr 11, 2006 by a Male patient taking Zaroxolyn (View Usage) (Dosage: ) . Location: UNITED STATES , 48 years of age, weighting 192.9 lb, After Zaroxolyn was administered, patient had the following side effects: hypokalaemia, syncope. Patient was hospitalized.

4915258-X | Hypokalaemia
on Feb 16, 2006 Female patient from UNITED STATES , weighting 123.0 lb, was treated with Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: hypokalaemia. Zaroxolyn dosage: 2.5 Mg (1/2 Tab) Po Qod Prior To Admission. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), PAXIL (View Paxil Review and Paxil Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), NORVASC (View Norvasc Review and Norvasc Label ), DICYCLOMINE (View Dicyclomine Review and Dicyclomine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LIPITOR (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

4894849-9 | Fluid Retention, Weight Abnormal
on Jan 26, 2006 Male patient from UNITED STATES , 43 years of age, weighting 186.0 lb, was diagnosed with cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?) and was treated with Zaroxolyn (View Usage). Patient had the following side effects: fluid retention, weight abnormal. Zaroxolyn dosage: 1 Dly. Patient was hospitalized.

4832110-9 | Arthritis Bacterial, Gout, Pain, Renal Impairment
Patient was taking Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: arthritis bacterial, gout (What is gout?), pain (What is pain?), renal impairment on Nov 02, 2005 from CANADA Additional patient health information: Female patient , 78 years of age, was diagnosed with hypertension, oedema and. Zaroxolyn dosage: 10 Mg /d Po. During the same period patient was treated with APRESOLINE (View Apresoline Review and Apresoline Label ), INSULIN RAPID (View Insulin Rapid Review and Insulin Rapid Label ), INSULIN ILETIN I (View Insulin Iletin I Review and Insulin Iletin I Label ), LASIX (View Lasix Review and Lasix Label ), PANALOC (View Panaloc Review and Panaloc Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized and became disabled.

4817389-1 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bicarbonate Increased, Blood Creatinine Increased, Blood Glucose Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Cardiac Failure Congestive, Condition Aggravated
Adverse event was reported on Oct 14, 2005 by a Male patient taking Zaroxolyn (View Usage) (Dosage: 2.5 Mg Prn Po) was diagnosed with cardiovascular disorder, cardiac failure and. Location: UNITED STATES , 60 years of age, weighting 207.0 lb, Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bicarbonate increased, blood creatinine increased, blood glucose increased, blood urea increased, brain natriuretic peptide increased, cardiac failure congestive, condition aggravated. During the same period patient was treated with K DUR 10 (View K-dur 10 Review and K-dur 10 Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

4809259-X | Arthritis Bacterial, Gout, Infection, Pain, Pain In Extremity
on Oct 11, 2005 Female patient from CANADA , 78 years of age, was diagnosed with hypertension, oedema and was treated with Zaroxolyn (View Usage). Patient had the following side effects: arthritis bacterial, gout (What is gout?), infection (What is infection?), pain (What is pain?), pain in extremity. Zaroxolyn dosage: 10 Mg/d Po. During the same period patient was treated with APRESOLINE (View Apresoline Review and Apresoline Label ), INSULIN RAPID /00030501/ (View Insulin Rapid /00030501/ Review and Insulin Rapid /00030501/ Label ), NPH ILETIN I (BEEF PORK) (View Nph Iletin I (beef-pork) Review and Nph Iletin I (beef-pork) Label ), LASIX /0032601/ (View Lasix /0032601/ Review and Lasix /0032601/ Label ), PANALOC (View Panaloc Review and Panaloc Label ). Patient was hospitalized.

4808027-2 | Blood Creatinine Increased, Blood Pressure Decreased, Blood Urea Increased, Cardiac Failure Congestive, Dizziness, Nausea, Nodule, Weight Increased
on Oct 07, 2005 Male patient from UNITED STATES , 48 years of age, weighting 271.2 lb, was diagnosed with cardiac failure congestive and was treated with Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: blood creatinine increased, blood pressure decreased, blood urea increased, cardiac failure congestive, dizziness (What is dizziness?), nausea (What is nausea?), nodule, weight increased. Zaroxolyn dosage: 2.5 Mg 3/w. During the same period patient was treated with LANOXIN (View Lanoxin Review and Lanoxin Label ), OXYCONTIN (View Oxycontin Review and Oxycontin Label ), DIOVAN (View Diovan Review and Diovan Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), COREG (View Coreg Review and Coreg Label ). Patient was hospitalized.

4778382-0 | Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bicarbonate Increased, Blood Creatinine Increased, Blood Glucose Increased, Blood Sodium Decreased, Blood Urea Increased, Cardiac Failure Congestive, Condition Aggravated
Patient was taking Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bicarbonate increased, blood creatinine increased, blood glucose increased, blood sodium decreased, blood urea increased, cardiac failure congestive, condition aggravated on Sep 06, 2005 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 207.0 lb, was diagnosed with cardiovascular disorder, cardiac failure and. Zaroxolyn dosage: 2.5 Mg Prn Po. During the same period patient was treated with LISINOPRIL (2.5 Mg 1/d Po) (View Lisinopril Review and Lisinopril Label ), DEMADEX (50 Mg 1/d Po) (View Demadex Review and Demadex Label ), BETAPACE (40 Mg 2/d Po) (View Betapace Review and Betapace Label ), K DUR 10 (View K-dur 10 Review and K-dur 10 Label ). Patient was hospitalized.

4759855-3 | Blood Chloride Decreased, Blood Creatinine Increased, Blood Potassium Decreased, Blood Sodium Decreased, Blood Urea Increased, Carbon Dioxide Increased, Oedema Peripheral
Adverse event was reported on Aug 31, 2005 by a Female patient taking Zaroxolyn (View Usage) (Dosage: 5 Mg Qam Po) was diagnosed with oedema peripheral and. Location: UNITED STATES , weighting 121.0 lb, Patient had the following side effects: blood chloride decreased, blood creatinine increased, blood potassium decreased, blood sodium decreased, blood urea increased, carbon dioxide increased, oedema peripheral. During the same period patient was treated with DEMADEX (View Demadex Review and Demadex Label ), COUMADIN (View Coumadin Review and Coumadin Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ZOCOR (View Zocor Review and Zocor Label ), NEXIUM (View Nexium Review and Nexium Label ), EVISTA (View Evista Review and Evista Label ), IMDUR (View Imdur Review and Imdur Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

4729953-9 | Neutropenia, White Blood Cell Count Decreased
on Jul 12, 2005 Female patient from UNITED STATES , 56 years of age, was treated with Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: neutropenia, white blood cell count decreased. Zaroxolyn dosage: . Patient was hospitalized.

4706524-1 | Rash
on Jan 14, 2005 Female patient from , weighting 424.0 lb, was diagnosed with hypertension and was treated with Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Zaroxolyn dosage: 5 Q D.

4673847-4 | Blood Creatine Increased, Deafness Neurosensory, Haemodialysis, Multi-organ Failure, Pancreatitis, Renal Impairment
Patient was taking Zaroxolyn (View Usage). Patient had the following side effects: blood creatine increased, deafness neurosensory, haemodialysis, multi-organ failure, pancreatitis, renal impairment on May 04, 2005 from Additional patient health information: Male patient , 56 years of age, was diagnosed with pancreatitis and. Zaroxolyn dosage: 5mg, Po.. During the same period patient was treated with FUROSEMIDE (10mg/ml, Iv.) (View Furosemide Review and Furosemide Label ), EDECRIN (50mg, Iv.) (View Edecrin Review and Edecrin Label ), NEBCIN (200mg, Po.) (View Nebcin Review and Nebcin Label ), FRAGMIN (View Fragmin Review and Fragmin Label ), MERONEM (MEROPENEM) (View Meronem (meropenem) Review and Meronem (meropenem) Label ), PANTOLOC (PANTOPRAZOLE) (View Pantoloc (pantoprazole) Review and Pantoloc (pantoprazole) Label ). Patient was hospitalized.

4647703-1 | Blood Creatinine Increased, Blood Urea Increased, Cardiac Failure Congestive, Dehydration, Hypotension
Adverse event was reported on Apr 15, 2005 by a Male patient taking Zaroxolyn (View Usage) (Dosage: ) . Location: , 62 years of age, After Zaroxolyn was administered, patient had the following side effects: blood creatinine increased, blood urea increased, cardiac failure congestive, dehydration, hypotension. During the same period patient was treated with BIBR 1048 (DABIGATRAN ETEXILATE) (150mg, 2/d, Po) (View Bibr 1048 (dabigatran Etexilate) Review and Bibr 1048 (dabigatran Etexilate) Label ).

4627362-4 | Blood Creatinine Increased, Blood Urea Increased, Dehydration, Hypotension
on Mar 17, 2005 Male patient from , 62 years of age, was treated with Zaroxolyn (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, dehydration, hypotension. Zaroxolyn dosage: . During the same period patient was treated with BIBR 1048 (DABIGATRAN ETEXILATE) (View Bibr 1048 (dabigatran Etexilate) Review and Bibr 1048 (dabigatran Etexilate) Label ).

4572182-2 | Anaemia, Anoxic Encephalopathy, Aspiration, Bradyarrhythmia, Cardiac Arrest, Cardiac Failure Congestive, Faecal Occult Blood Positive, Gastritis, Graft Thrombosis
on Jan 19, 2005 Male patient from , 53 years of age, was diagnosed with fluid retention, diabetes mellitus, hypertension, depression (What is depression?) and was treated with Zaroxolyn (View Usage). Patient had the following side effects: anaemia, anoxic encephalopathy, aspiration, bradyarrhythmia, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, faecal occult blood positive, gastritis, graft thrombosis. Zaroxolyn dosage: Frequency, And Route. During the same period patient was treated with MICARDIS (View Micardis Review and Micardis Label ), COZAAR (View Cozaar Review and Cozaar Label ), NOVOLIN 85/15 (View Novolin 85/15 Review and Novolin 85/15 Label ), HUMALOG (View Humalog Review and Humalog Label ), FUROSEMIDE (FUROSEMIDE) (View Furosemide (furosemide) Review and Furosemide (furosemide) Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), PLAVIX (Prevent Thrombosis) (View Plavix Review and Plavix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ).

4571490-9 | Rash
Patient was taking Zaroxolyn (View Usage). After Zaroxolyn was administered, patient had the following side effects: rash (What is rash?) on Feb 03, 2005 from Additional patient health information: Female patient , weighting 424.0 lb, was diagnosed with hypertension and. Zaroxolyn dosage: One Qd.

4570179-X | Anaemia, Anoxic Encephalopathy, Aspiration, Bacteria Sputum Identified, Bradyarrhythmia, Cardiac Arrest, Cardiac Failure Congestive, Chest Wall Pain, Dependence On Respirator
Adverse event was reported on Aug 11, 2004 by a Male patient taking Zaroxolyn (View Usage) (Dosage: Dose: Unk) was diagnosed with fluid retention, hypertension, diabetes mellitus, depression (What is depression?), thrombosis prophylaxis and. Location: , 53 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, anoxic encephalopathy, aspiration, bacteria sputum identified, bradyarrhythmia, cardiac arrest (What is cardiac arrest?), cardiac failure congestive, chest wall pain, dependence on respirator. During the same period patient was treated with FUROSEMIDE (Dose: Unk) (View Furosemide Review and Furosemide Label ), MICARDIS (Dose: Unk) (View Micardis Review and Micardis Label ), COZAAR (Dose: Unk) (View Cozaar Review and Cozaar Label ), HUMULIN (Dose: Unk) (View Humulin Review and Humulin Label ), HUMALOG (Dose: Unk) (View Humalog Review and Humalog Label ), ZOLOFT (Dose: Unk) (View Zoloft Review and Zoloft Label ), PLAVIX (Dose: Unk) (View Plavix Review and Plavix Label ), TOPROL XL (Dose: Unk) (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.

4556724-9 | Abasia, Anorexia, Asthenia, Condition Aggravated, Constipation, Culture Urine Positive, Hypokalaemia, Hyponatraemia
on Dec 30, 2004 Male patient from , 70 years of age, was diagnosed with hypertension and was treated with Zaroxolyn (View Usage). Patient had the following side effects: abasia, anorexia, asthenia, condition aggravated, constipation (What is constipation?), culture urine positive, hypokalaemia, hyponatraemia. Zaroxolyn dosage: . During the same period patient was treated with LOSARTAN 50/100 (LOSARTAN) (View Losartan 50/100 (losartan) Review and Losartan 50/100 (losartan) Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.